130 related articles for article (PubMed ID: 17174106)
21. Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds.
Wang YA; Johnson SK; Brown BL; Dobson PR
Oncol Rep; 2009 Feb; 21(2):437-42. PubMed ID: 19148520
[TBL] [Abstract][Full Text] [Related]
22. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy.
Villa AM; Caporizzo E; Papagni A; Miozzo L; Del Buttero P; Grilli MD; Amboldi N; Fazio F; Doglia SM; Giglioni B
Eur J Cancer; 2005 Jul; 41(10):1453-9. PubMed ID: 15913986
[TBL] [Abstract][Full Text] [Related]
23. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.
Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH
Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542
[TBL] [Abstract][Full Text] [Related]
24. Engery-filtering transmission electron microscopy of biological specimens.
de Bruijn WC; Sorber CW; Gelsema ES; Beckers AL; Jongkind JF
Scanning Microsc; 1993 Jun; 7(2):693-708; discussion 709. PubMed ID: 9026905
[TBL] [Abstract][Full Text] [Related]
25. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines.
Rogalska A; Koceva-Chyła A; Jóźwiak Z
Chem Biol Interact; 2008 Oct; 176(1):58-70. PubMed ID: 18692031
[TBL] [Abstract][Full Text] [Related]
26. [Preparation of doxorubicin encapsulated in amphiphilic polysaccharide nanoparticles and anti-hepatocarcinoma effect thereof].
Huang YF; Gu WL; Li ZH; Chen RF; Zhou JJ; Zhou QB; Guo N
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):810-2. PubMed ID: 19595118
[TBL] [Abstract][Full Text] [Related]
27. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
[TBL] [Abstract][Full Text] [Related]
28. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
[TBL] [Abstract][Full Text] [Related]
29. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
[TBL] [Abstract][Full Text] [Related]
30. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cancer Chemother Pharmacol; 2009 Sep; 64(4):811-27. PubMed ID: 19184017
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
33. Chromatin loop size in human leukemia (HL-60) cells.
Tohno Y; Tohno S; Tanaka Y
J Electron Microsc (Tokyo); 1995 Feb; 44(1):35-8. PubMed ID: 7751831
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
[TBL] [Abstract][Full Text] [Related]
36. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
37. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
[TBL] [Abstract][Full Text] [Related]
38. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
[TBL] [Abstract][Full Text] [Related]
39. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers.
Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y
Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
